Business Wire

AMAALA

4.11.2020 13:32:11 CET | Business Wire | Press release

Share
AMAALA and OceanoScientific Steer Environmental Research Sailing Expedition

AMAALA, the ultra-luxury destination located along Saudi Arabia’s north western coast, took to the seas with Monaco-based OceanoScientific on a two-week scientific expedition. The expedition was in line with AMAALA’s desire to measure and understand the impact of river water pollutants on human and sea life.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201104005308/en/

The expedition was undertaken with a two-fold objective to determine the nature and density of the chemical compounds that affect the marine environment. It also placed a wider focus on the impact of chemical contaminants on the ocean and human health, and validates the applicability of the expedition’s sampling method, using a cost-effective research alternative with a zero-carbon emission vessel.

Over the course of two weeks, the crew collected water samples from various points within a triangle of 1,500 nautical miles in the western Mediterranean.

These samples were handed over to the Institut Français de Recherche pour l'Exploitation de la Mer (Ifremer) by the crew and AMAALA Chief Executive Officer Nicholas Naples and Chief Sustainability Officer Brendan Jack at the last port of call in La Seyne-sur-Mer, France. The scientists at the Ifremer, who advised on the scientific aspects of the undertaking, will now quantify and analyse the concentration of metals and elements such as cadmium, lead, nickel and mercury, all of which can alter the composition of the sea and affect the marine food chain.

The expedition and the results unearthed as part of its study will inform AMAALA’s own conservation efforts. The Red Sea and the Mediterranean Sea are neighbouring seas and part of one global ocean system where changes in one, create ripples in the other. With its vibrant coral gardens and rich underwater life, the Red Sea coast at AMAALA has a thriving ecosystem that the destination aims to preserve and nurture. To this end, it has forged partnerships with global marine conservation entities, including the Prince Albert II of Monaco Foundation, the Centre Scientifique de Monaco, and the Oceanographic Institute.

Commenting on the expedition, AMAALA Chief Executive Officer Nicholas Naples, said “We are proud to sponsor the OceanoScientific Expedition – it perfectly aligns with our goal to create a luxury destination that is a global leader in sustainable tourism. Being part of expeditions and studies like this, arms us with the deeper insight and scientific knowledge required to preserve and protect our local ecosystem, especially the Red Sea coral reefs. This expedition also illustrates our vision of creating experiences that brings diverse interests and cultures together.”

Yvan Griboval, circumnavigator explorer and member of the Yacht Club de Monaco, who led the expedition said, “While almost everyone has realised that plastic pollution is an appalling scourge on the ocean, we want to show that chemical contaminants - metallic and organic - that pollute the sea and poison the phytoplankton and plankton at the start of the food chain, are found in our dinner plates at the other end of the chain of life.”

The expedition was conducted on the specially commissioned AMAALA Explorer, a former record-breaking 110-foot racing maxi-catamaran that was converted into a scientific research ship with zero carbon emissions. It functioned as the expedition’s lodging and lab.

HSH Prince Albert II of Monaco on 15 October 2020 was on hand to bid the crew farewell from the marina of the Yacht Club de Monaco. The AMAALA Explorer made port calls in Porto Cervo, Italy; Barcelona, Spain; and La Seyne-sur-Mer, France where water samples were handed over to scientists, before returning to Monaco.

The vessel and expedition were skippered by Yvan Griboval, who worked with a team of scientists specialised in the study of organic contaminants, including an onboard Swedish marine scientist Linn Sekund and AMAALA Director of Sports Marc Archer.

A short documentary film about the expedition, in English and French, will be distributed in 2021, along with scientific results in late 2021 and scientific publication in late 2023.

*Source: AETOSWire

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing23.3.2026 07:00:00 CET | Press release

The United States (U.S.) Food and Drug Administration (FDA) has approved Restylane Contour* for the correction of temple hollowing, expanding its use beyond cheek augmentation and midface contour deficiencies to support overall facial balance and harmony1-3 The approval is based on clinical data showing Restylane Contour, part of Galderma’s versatile portfolio of hyaluronic acid injectables, delivers natural-looking results lasting for up to 18 months and high patient satisfaction1,2 This follows the recent U.S. FDA approval for Restylane Lyft™ for the enhancement of the chin profile and the debut of the ‘Wake Up to Restylane’ campaign in the U.S., highlighting Galderma’s commitment to continuing to evolve this versatile portfolio to meet emerging and diverse needs, including the desire for effortless, ‘wake‑up‑ready’ beauty4 Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the U.S. FDA has approved Restylane Contour for the correction of temple hol

Paving the Way for Real‑Time Earth Observation: Space Compass and SWISSto12 Sign Contract for First Commercial GEO Optical Data Relay Satellite23.3.2026 05:00:00 CET | Press release

Space Compass Corporation (“Space Compass”) and SWISSto12 SA (“SWISSto12”) announced today that they have executed a procurement contract for the first GEO optical data relay satellite. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260320584108/en/ (From Left to Right): Julie Pignon, Legal Counsel, SWISSto12; 倉田 るり子 (Ruriko Kurata), Legal Counsel, Space Compass; 小松 大実 (Hiromi Komatsu), Co-CEO, Space Compass; 田中 良太 (Ryota Tanaka), Engineering Director, Space Compass; Emile de Rijk, CEO, SWISSto12; Fredrik Gustavsson, Chief Financial and Strategy Officer, SWISSto12. This agreement represents a major milestone toward the realization of Space Compass’s optical data relay service. With high-speed, high-capacity optical data relay service, Space Compass aims to transform Earth Observation from just a tracking record into a real-time decision-making tool. For SWISSto12, the contract represents further validation of the company’s a

Andersen Consulting styrker sit cybersikkerhedstilbud gennem samarbejde med Trillium Information Security Systems21.3.2026 02:16:00 CET | Pressemeddelelse

Andersen Consulting udbygger sine kompetencer inden for teknologi og risikostyring gennem en samarbejdsaftale med Trillium Information Security Systems (TISS), et cybersikkerhedsfirma. Med en tilstedeværelse i Canada og Pakistan leverer TISS omfattende cybersikkerhedsløsninger til organisationer inden for finans, telekommunikation og den offentlige sektor. Virksomhedens team tilbyder et bredt udvalg af ydelser, herunder sikkerhedsvurderinger, managed security operations, red team-tjenester, digital efterforskning og hændelsesrespons samt GRC-rådgivning. Med næsten to årtiers erfaring leverer TISS adaptive, efterretningsdrevne forsvarsmekanismer, der hjælper kunder med at forudse og reagere på cybertrusler, der er i konstant udvikling. "Hos TISS arbejder vi på at skabe et mere sikkert digitalt miljø ved at give organisationer mulighed for at operere sikkert og med selvtillid," udtalte Mahir Mohsin Sheikh, administrerende direktør for TISS. "Vores samarbejde med Andersen Consulting giver

Andersen Consulting udvider sin teknologiplatform i Frankrig20.3.2026 17:28:00 CET | Pressemeddelelse

Andersen Consulting udvider sit udbud inden for digital transformation med en samarbejdsaftale med Teolia Consulting, et fransk firma, der specialiserer sig i projekt- og produktstyring, cloud-platformsudvikling, datatransformation samt implementering og brug af Atlassian-pakken. Teolia Consulting blev grundlagt i 2014 og hjælper organisationer med at opnå digital performance, fra agile metoder til løsninger, der reducerer lanceringstiden. Virksomhedens ekspertise består i at levere integrerede strategier, der bringer teknologi og organisatorisk forandring i overensstemmelse. Virksomheden arbejder på tværs af brancher, herunder inden for bank- og finanssektoren, forsikring, mode og detailhandel, og hjælper kunder med at få større robusthed og accelerere deres digitale modenhed. "Hos Teolia Consulting mener vi, at ægte transformation opstår, når teknologi og mennesker udvikler sig sammen," sagde Lucienne Jacquet, der er administrerende partner i Teolia. "Ved at samarbejde med Andersen C

Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting20.3.2026 15:00:00 CET | Press release

- New, late-breaking 54-week data for povorcitinib in hidradenitis suppurativa (STOP-HS1 & STOP-HS2) to be highlighted - Featured abstracts for ruxolitinib cream (Opzelura®) and povorcitinib include multiple ePosters in atopic dermatitis, hidradenitis suppurativa and vitiligo Incyte (Nasdaq:INCY) today announced that data from key programs in its Inflammation and Autoimmunity (IAI) franchise will be presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting, to be held March 27 – 31, 2026, in Denver. “At AAD 2026, we are presenting late‑breaking 54-week results from the Phase 3 STOP‑HS program evaluating povorcitinib in hidradenitis suppurativa (HS),” said Jim Lee, M.D., Ph.D., Group Vice President, Inflammation and Autoimmunity, Incyte. “These data provide longer term evidence of the safety and efficacy of povorcitinib in HS patients and further strengthen the significant growth potential of our Inflammation and Autoimmunity franchise.” Details on key data presentation

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye